TrialInfection and immunity1999

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

J A Benítez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.